Literature DB >> 12525818

Major bleeding and severe thrombocytopenia after combined heparin and abciximab-c7E3 Fab therapy.

L G Y Claeys1, W Berg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12525818     DOI: 10.1053/ejvs.2002.1757

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


× No keyword cloud information.
  3 in total

1.  Abciximab-induced acute profound thrombocytopenia postpercutaneous coronary intervention.

Authors:  Todd Golden; Sehem Ghazala; Rita Wadeea; Shilpa Junna
Journal:  BMJ Case Rep       Date:  2017-07-14

2.  Acute profound abciximab induced thrombocytopenia: a correct management of a methodological error.

Authors:  Gaetano Tanzilli; Martina Sordi; Alessio Arrivi; Enrico Mangieri; Massimiliano Scappaticci
Journal:  BMJ Case Rep       Date:  2009-10-05

3.  Acute Profound Thrombocytopenia after Using Abciximab for No-Reflow during Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction.

Authors:  Soonyoung Park; Jooyoung Lee; Sang Yeub Lee; Jang-Whan Bae; Kyung-Kuk Hwang; Dong-Woon Kim; Myeong-Chan Cho; Sang Min Kim
Journal:  Korean Circ J       Date:  2013-08-31       Impact factor: 3.243

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.